08.18.25 -- The Latest On CRISPR Deployment In TIL Therapy Development

Keep your cells thriving. Learn the essential cell culture media change protocol, including frequency, steps, and tips for optimal cell growth. Discover best practices and avoid common pitfalls.

Despite challenges with mammalian host cell line diversity, Lonza's mitigation strategies drive efficiency and reproducibility, maximizing cell growth and product quality.

Build a reliable, de-risked path to the clinic while avoiding unforeseen costs and compliance-related delays with advice from Suparna Sanyal, PhD, Head of Viral Vectors Commercial Development.

Spent media analysis continues to be an essential part of many media development workflows. Newer techniques, however, using state-of-the-art analytical technology, are becoming more popular.

Learn about an innovative tool that offers direct analysis of spent media, revealing key product quality attributes (PQAs) of monoclonal antibodies (mAbs) that ensure optimal mAb quality and productivity.

See how billions of γδ T cells can be generated from peripheral blood mononuclear cells with a chemically defined, non-animal origin, serum-free medium in a rocking motion platform.

Gain insight into the benefits of a next-generation CLD platform that delivers consistent quality, scalable performance and flexible expression solutions tailored to the demands of complex molecules.

Compare and contrast the performance of two stirred bioreactor types during the expansion of erythroblast cultures when a repeated batch cultivation strategy was used.